688 related articles for article (PubMed ID: 26126159)
21. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy.
Luna RA; Gilbert E; Hunter JG
Curr Opin Gastroenterol; 2012 Jul; 28(4):362-9. PubMed ID: 22517568
[TBL] [Abstract][Full Text] [Related]
22. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
Ganz RA; Overholt BF; Sharma VK; Fleischer DE; Shaheen NJ; Lightdale CJ; Freeman SR; Pruitt RE; Urayama SM; Gress F; Pavey DA; Branch MS; Savides TJ; Chang KJ; Muthusamy VR; Bohorfoush AG; Pace SC; DeMeester SR; Eysselein VE; Panjehpour M; Triadafilopoulos G;
Gastrointest Endosc; 2008 Jul; 68(1):35-40. PubMed ID: 18355819
[TBL] [Abstract][Full Text] [Related]
23. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
[TBL] [Abstract][Full Text] [Related]
24. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry.
Li N; Pasricha S; Bulsiewicz WJ; Pruitt RE; Komanduri S; Wolfsen HC; Chmielewski GW; Corbett FS; Chang KJ; Shaheen NJ
Dis Esophagus; 2016 Aug; 29(6):537-43. PubMed ID: 26121935
[TBL] [Abstract][Full Text] [Related]
25. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue.
Bowman CJ; Zhang R; Balitzer D; Wang D; Rabinovitch PS; Kővári BP; Mattis AN; Kakar S; Lauwers GY; Choi WT
Mod Pathol; 2021 Oct; 34(10):1889-1900. PubMed ID: 34108638
[TBL] [Abstract][Full Text] [Related]
26. The impact of endoscopic ultrasound findings on clinical decision making in Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
Bulsiewicz WJ; Dellon ES; Rogers AJ; Pasricha S; Madanick RD; Grimm IS; Shaheen NJ
Dis Esophagus; 2014 Jul; 27(5):409-17. PubMed ID: 23016606
[TBL] [Abstract][Full Text] [Related]
27. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.
Thota PN; Sada A; Sanaka MR; Jang S; Lopez R; Goldblum JR; Liu X; Dumot JA; Vargo J; Zuccarro G
Surg Endosc; 2017 Mar; 31(3):1336-1341. PubMed ID: 27444824
[TBL] [Abstract][Full Text] [Related]
28. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?
Konda VJ; Ferguson MK
World J Gastroenterol; 2010 Aug; 16(30):3786-92. PubMed ID: 20698041
[TBL] [Abstract][Full Text] [Related]
29. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
Phoa KN; Pouw RE; Bisschops R; Pech O; Ragunath K; Weusten BL; Schumacher B; Rembacken B; Meining A; Messmann H; Schoon EJ; Gossner L; Mannath J; Seldenrijk CA; Visser M; Lerut T; Seewald S; ten Kate FJ; Ell C; Neuhaus H; Bergman JJ
Gut; 2016 Apr; 65(4):555-62. PubMed ID: 25731874
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
Al Natour RH; Catanzaro A; Zolotarevsky E; DeBenedet AT; Gunaratnam NT
Dis Esophagus; 2018 Jan; 31(1):1-6. PubMed ID: 29087500
[TBL] [Abstract][Full Text] [Related]
31. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett's esophagus: a critical assessment of histologic outcomes and adverse events.
Chadwick G; Groene O; Markar SR; Hoare J; Cromwell D; Hanna GB
Gastrointest Endosc; 2014 May; 79(5):718-731.e3. PubMed ID: 24462170
[TBL] [Abstract][Full Text] [Related]
32. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett's esophagus.
Canto MI; Shin EJ; Khashab MA; Molena D; Okolo P; Montgomery E; Pasricha P
Endoscopy; 2015 Jul; 47(7):582-91. PubMed ID: 25826275
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center.
Perry KA; Walker JP; Salazar M; Suzo A; Hazey JW; Melvin WS
Surg Endosc; 2014 Mar; 28(3):777-82. PubMed ID: 24122245
[TBL] [Abstract][Full Text] [Related]
39. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
